Pacira BioSciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May '26 May 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	914	1,064	871	1,568	1,773	2,692
Market Cap Growth	-19.30%	22.15%	-44.45%	-11.56%	-34.12%	3.08%
Enterprise Value	1,123	1,278	594.4	1,415	1,669	2,106
Last Close Price	23.22	25.88	18.84	33.74	38.61	60.17
PE Ratio	194.84	161.75	-	37.91	113.56	65.40
Forward PE	7.55	7.53	7.10	10.23	11.64	15.43
PEG Ratio	-	0.61	0.61	0.61	0.66	0.66
PS Ratio	1.24	1.46	1.24	2.32	2.66	4.97
P/FCF Ratio	6.88	-	4.87	11.24	15.39	33.71
P/OCF Ratio	6.42	-	4.60	10.14	12.21	21.41
EV/Sales Ratio	1.53	1.76	0.85	2.10	2.50	3.89
EV/EBITDA Ratio	9.26	66.58	109.79	8.67	11.02	17.78
EV/EBIT Ratio	37.30	66.58	-	16.14	27.81	23.42
EV/FCF Ratio	8.46	-	3.33	10.14	14.49	26.38
Debt / EBITDA Ratio	15.25	19.39	-	-	-	-
Net Debt / EBITDA Ratio	9.27	11.13	-51.12	-0.94	-0.69	-4.94
Net Debt / FCF Ratio	-	-	-1.55	-1.10	-0.90	-7.33
Asset Turnover	4.85	3.34	3.26	5.24	1.93	1.58
Return on Assets (ROA)	6.21%	3.68%	-53.83%	46.32%	20.82%	19.53%
Return on Capital Employed (ROCE)	15.92%	8.82%	-34.12%	68.11%	17.41%	26.23%
Earnings Yield	0.56%	0.62%	-	2.64%	0.88%	1.53%
FCF Yield	14.52%	0.00%	20.52%	8.89%	6.50%	2.97%
Buyback Yield / Dilution	5.52%	2.60%	11.03%	-11.69%	-1.99%	-4.46%
Total Shareholder Return	5.52%	2.60%	11.03%	-11.69%	-1.99%	-4.46%

SEC Filings: 10-K · 10-Q